NightstaRx's Series B Round

NightstaRx raised a round of funding on November 09, 2015.

Nightstar is a private biopharmaceutical company focused on the development of therapies for retinal dystrophies. The Company's lead program is a retinal gene therapy for Choroideremia, a rare inherit…

Articles about NightstaRx's Series B Round: